Large-scale testing (Phase 3)WithdrawnNCT00175864
What this trial is testing
Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.
Who this might be right for
Epilepsy
UCB Pharma